Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/24482
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarcía Romero, Luis José-
dc.contributor.authorValls Puig, Juan Carlos-
dc.date.accessioned2026-06-09T17:34:07Z-
dc.date.available2026-06-09T17:34:07Z-
dc.date.issued2004-11-26-
dc.identifier.urihttps://saber.ucv.ve/jspui/handle/10872/24482-
dc.descriptionUniversidad Central de Venezuela, Facultad de Medicina, Comisión de Estudios de Postgrado. Institut° de Oncologia "Dr. Luis Razetti", Trabajo Especial de Investigación que se Presenta para Optar al Título de Especialista en Cirugía Oncológicaen_US
dc.description.abstractPROBLEMA. El cancer (CA) ginecologico constituye causa importante de morbi mortalidad. La diseminacion linfatica posee importancia como factor pron6stico y terapeutico. OBJETIVO: Evaluar la linfadenectomia pelvica en CA de cuello uterino, endometrio y ovario como elemento pronostico y terapeutico. METODO: Estudio descriptivo retrospectivo de una muestra seleccionada de 117 pacientes, 43 con CA de Cuello Uterino, 36 CA de endometrio y 38 CA de Ovario, entre enero 2000 y diciembre 2002. Seguimiento: 12-48 meses. Analisis mediante frecuencias relativas y Prueba exacta de Fisher. RESULTADOS: CUELLO UTERINO: Linfadenectomia a 79% de las pacientes. Grado tumoral: iinico factor pronostico significativo. ENDOMETRIO: Linfadenectomia efectuada al 58,33%. Factores pronosticos sin significancia estadistica. OVARIO: Linfadenectomia realizada al 28%. Factores pronosticos sin significancia estadistica. CONCLUSIONES: La linfadenectomia no fue factor pronostico para recaida y/o persistencia, no agrego complicaciones. El promedio de ganglios obtenidos y metastaticos the inferior a la literatura. Problem. Gynecologic cancer (gc) is a major cause of morbidity and mortality. Lymphatic spread is important as a prognostic and therapeutic factor. Objective: to evaluate pelvic lymphadenectomy in cervical, endometrial, and ovarian cancer as a prognostic and therapeutic element. Method: retrospective descriptive study of a selected sample of 117 patients: 43 with cervical cancer, 36 with endometrial cancer, and 38 with ovarian cancer, between january 2000 and december 2002. Follow-up: 12–48 months. Analysis using relative frequencies and fisher's exact test. Results: cervix: lymphadenectomy in 79% of patients. Tumor grade: the only significant prognostic factor. Endometrium: lymphadenectomy performed in 58.33%. Prognostic factors without statistical significance. Ovary: lymphadenectomy performed in 28% of cases. Prognostic factors without statistical significance. Conclusions: lymphadenectomy was not a prognostic factor for relapse and/or persistence, nor did it add complications. The average number of lymph nodes obtained and metastatic was lower than reported in the literatureen_US
dc.language.isoesen_US
dc.subjectCarcinomaen_US
dc.subjectLinfadenectomiaen_US
dc.subjectFactores Pronosticosen_US
dc.subjectRecaidaen_US
dc.subjectCuello Uterinoen_US
dc.subjectEndometrioen_US
dc.subjectOvarioen_US
dc.subjectCarcinomaen_US
dc.subjectLymphadenectomyen_US
dc.subjectPrognostic Factorsen_US
dc.subjectRecurrenceen_US
dc.subjectCervixen_US
dc.subjectEndometriumen_US
dc.subjectOvaryen_US
dc.subjectTrabajo de Gradoen_US
dc.subjectFacultad de Medicinaen_US
dc.subjectCirugía Oncológicaen_US
dc.titleLintadenectomia Pélvica en Cáncer Ginecológicoen_US
dc.typeThesisen_US
Appears in Collections:Otras (Especializaciones)

Files in This Item:
File Description SizeFormat 
García Luis; Valls Juan.pdf24.58 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.